1. Home
  2. JAGX vs CRIS Comparison

JAGX vs CRIS Comparison

Compare JAGX & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$0.40

Market Cap

1.0M

Sector

Health Care

ML Signal

HOLD

Logo Curis Inc.

CRIS

Curis Inc.

HOLD

Current Price

$0.45

Market Cap

976.1K

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAGX
CRIS
Founded
2013
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0M
976.1K
IPO Year
2014
2000

Fundamental Metrics

Financial Performance
Metric
JAGX
CRIS
Price
$0.40
$0.45
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $30.33
AVG Volume (30 Days)
686.5K
★ 6.1M
Earning Date
11-16-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
82.42
★ 91.57
EPS
N/A
★ N/A
Revenue
★ $11,511,000.00
$9,898,000.00
Revenue This Year
$77.78
N/A
Revenue Next Year
N/A
$604.76
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 31.50
52 Week Low
$0.20
$0.33
52 Week High
$41.53
$2,880.00

Technical Indicators

Market Signals
Indicator
JAGX
CRIS
Relative Strength Index (RSI) 39.52 29.07
Support Level $0.29 $0.33
Resistance Level $0.46 $1.60
Average True Range (ATR) 0.12 0.22
MACD 0.00 0.19
Stochastic Oscillator 2.13 2.26

Price Performance

Historical Comparison
JAGX
CRIS

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: